Identification of serotype-specific T cell responses to highly conserved regions of the dengue viruses

Clinical and Experimental Immunology

Volumn 168, Issue 2, 2012, Pages 215-223

  Malavige, G N ^a,b   McGowan, S ^d   Atukorale, V ^a   Salimi, M ^b   Peelawatta, M ^a   Fernando, N ^a   Jayaratne, S D ^a   Ogg, G ^b,c  

^a UNIVERSITY OF SRI JAYEWARDENEPURA   (Sri Lanka)

^b NIHR OXFORD BIOMEDICAL RESEARCH CENTRE   (United Kingdom)

^c CHURCHILL HOSPITAL   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Dengue viruses; Highly conserved; Non cross reactive; Serotype specific; T cells

Indexed keywords

EPITOPE; NONSTRUCTURAL PROTEIN 2; NONSTRUCTURAL PROTEIN 4A;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DENGUE VIRUS; DISEASE TRANSMISSION; ENZYME LINKED IMMUNOSPOT ASSAY; EX VIVO STUDY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOGENICITY; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; SRI LANKA; T LYMPHOCYTE;

ADULT; AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, VIRAL; CELL LINE; CONSERVED SEQUENCE; CROSS REACTIONS; DENGUE; DENGUE VIRUS; EPITOPES; HLA ANTIGENS; HUMANS; IMMUNOLOGIC MEMORY; MICE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PEPTIDES; SEROTYPING; T-LYMPHOCYTES; VIRAL PROTEINS;

EID: 84859244181     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2012.04566.x     Document Type: Article

References (27)

1. Callaway E. Dengue fever climbs the social ladder. Nature 2007; 448:734-5.
2. Mathew A, Rothman AL. Understanding the contribution of cellular immunity to dengue disease pathogenesis. Immunol Rev 2008; 225:300-13.
3. Stephens HA, Klaythong R, Sirikong M etal. HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais. Tissue Antigens 2002; 60:309-18.
4. Lan NT, Kikuchi M, Huong VT etal. Protective and enhancing HLA alleles, HLA-DRB1*0901 and HLA-A*24, for severe forms of dengue virus infection, dengue hemorrhagic fever and dengue shock syndrome. PLoS Negl Trop Dis 2008; 2:e304.
5. Weaver SC, Vasilakis N. Molecular evolution of dengue viruses: contributions of phylogenetics to understanding the history and epidemiology of the preeminent arboviral disease. Infect Genet Evol 2009; 9:523-40.
6. Imrie A, Meeks J, Gurary A etal. Differential functional avidity of dengue virus-specific T-cell clones for variant peptides representing heterologous and previously encountered serotypes. J Virol 2007; 81:10081-91.
7. Appanna R, Huat TL, See LL, Tan PL, Vadivelu J, Devi S. Cross-reactive T-cell responses to the nonstructural regions of dengue viruses among dengue fever and dengue hemorrhagic fever patients in Malaysia. Clin Vaccine Immunol 2007; 14:969-77.
8. Dong T, Moran E, Vinh Chau N etal. High pro-inflammatory cytokine secretion and loss of high avidity cross-reactive cytotoxic T-cells during the course of secondary dengue virus infection. PLoS ONE 2007; 2:e1192.
9. Mangada MM, Rothman AL. Altered cytokine responses of dengue-specific CD4+ T cells to heterologous serotypes. J Immunol 2005; 175:2676-83.
10. Gagnon SJ, Mori M, Kurane I etal. Cytokine gene expression and protein production in peripheral blood mononuclear cells of children with acute dengue virus infections. J Med Virol 2002; 67:41-6.
11. Mongkolsapaya J, Duangchinda T, Dejnirattisai W etal. T cell responses in dengue hemorrhagic fever: are cross-reactive T cells suboptimal? J Immunol 2006; 176:3821-9.
12. Moran E, Simmons C, Vinh Chau N etal. Preservation of a critical epitope core region is associated with the high degree of flaviviral cross-reactivity exhibited by a dengue-specific CD4+ T cell clone. Eur J Immunol 2008; 38:1050-7.
13. Simmons CP, Dong T, Chau NV etal. Early T-cell responses to dengue virus epitopes in Vietnamese adults with secondary dengue virus infections. J Virol 2005; 79:5665-75.
14. Messer WB, Vitarana UT, Sivananthan K etal. Epidemiology of dengue in Sri Lanka before and after the emergence of epidemic dengue hemorrhagic fever. Am J Trop Med Hyg 2002; 66:765-73.
15. Kanakaratne N, Wahala WM, Messer WB etal. Severe dengue epidemics in Sri Lanka, 2003-2006. Emerg Infect Dis 2009; 15:192-9.
16. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol 1990; 215:403-10.
17. Rice P, Longden I, Bleasby A. EMBOSS: the European Molecular Biology Open Software Suite. Trends Genet 2000; 16:276-7.
18. + T cells show evidence of recent activation and effector differentiation, consistent with frequent exposure to replicative cycle antigens in healthy immune donors. Clin Exp Immunol 2008; 152:522-31.
19. Malavige GN, Fernando S, Aaskov J etal. Seroprevalence of anti-dengue virus antibodies in children in the Colombo district. Dengue Bull 2006; 30:68-71.
20. Rico-Hesse R. Microevolution and virulence of dengue viruses. Adv Virus Res 2003; 59:315-41.
21. Cologna R, Armstrong PM, Rico-Hesse R. Selection for virulent dengue viruses occurs in humans and mosquitoes. J Virol 2005; 79:853-9.
22. Rico-Hesse R, Harrison LM, Salas RA etal. Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. Virology 1997; 230:244-51.
23. Balmaseda A, Hammond SN, Perez L etal. Serotype-specific differences in clinical manifestations of dengue. Am J Trop Med Hyg 2006; 74:449-56.
24. Nisalak A, Endy TP, Nimmannitya S etal. Serotype-specific dengue virus circulation and dengue disease in Bangkok, Thailand from 1973 to 1999. Am J Trop Med Hyg 2003; 68:191-202.
25. Messer WB, Gubler DJ, Harris E, Sivananthan K, de Silva AM. Emergence and global spread of a dengue serotype 3, subtype III virus. Emerg Infect Dis 2003; 9:800-9.
26. Appanna R, Ponnampalavanar S, Lum Chai See L, Sekaran SD. Susceptible and protective HLA class 1 alleles against dengue fever and dengue hemorrhagic fever patients in a Malaysian population. PLoS ONE 2010; 5:e13029.
27. Martina BE, Koraka P, Osterhaus AD. Dengue virus pathogenesis: an integrated view. Clin Microbiol Rev 2009; 22:564-81.